Compare Illumina, Inc. (ILMN) vs Vanguard Sht-Term Inflation-Protected Sec Idx ETF (VTIP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illumina, Inc. vs Vanguard Sht-Term Inflation-Protected Sec Idx ETF — how do they compare? Illumina, Inc. trades at $192.1 (market cap $27.94B), while Vanguard Sht-Term Inflation-Protected Sec Idx ETF trades at $49.65. The key difference: Illumina, Inc. is trading nearer its 52-week high, Vanguard Sht-Term Inflation-Protected Sec Idx ETF nearer its low. Which is the better fit depends on your goals.
| ILMN | VTIP | |
|---|---|---|
Market Cap | $27.94B | — |
Sector | Health | — |
52-Week High | $194.33 | $50.75 |
52-Week Low | $91.00 | $49.39 |
Enterprise Value | $29.33B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
VTIP trades at $49.665, down 0.07% on the day, with a mixed technical outlook showing a bullish overall signal but bearish moving averages. The ETF focuses on short-term inflation-protected securities, offering a hedge against rising costs. Recent institutional buying includes a 239.8% position increase by Cwm LLC as of April 2026, signaling confidence. A dividend of $0.68 is scheduled for July 2026, providing income appeal.
Outlook remains cautious as the Fed signals no rate cuts in 2026, potentially limiting bond upside. VTIP's inflation hedge is relevant with CPI at 3.8% in April 2026, but short-term rate sensitivity poses risks. The ETF suits defensive portfolios seeking inflation protection, though volatility may persist amid economic uncertainty.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →About Vanguard Sht-Term Inflation-Protected Sec Idx ETF
The index is a market-capitalization-weighted index that includes all inflation-protected public obligations issued by the US Treasury with remaining maturities of less than 5 years. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the securities that make up the index, holding each security in approximately the same proportion as its weighting in the index.
Read more on VTIP →
